Below is a sample dispensing label for Jakafi (fedratinib) 20 mg tablets.
Feel free to adjust the wording, quantities, and regulatory details to match your local pharmacy practice and state/national labeling requirements.
---
📄 Sample Jakafi Dispensing Label (20 mg)
| Field | Content |
|-----------|-------------|
| Pharmacy Name & Address | Your Pharmacy
1234 Health Ave, Suite 100
City, State ZIP |
| Pharmacy Phone | (555) 123‑4567 |
| Date Dispensed | MM/DD/YYYY |
| Patient Name | _______________________ |
| Prescriber | Dr. ___________________ |
| Prescriber Phone | (555) 987‑6543 |
| Medication | Jakafi 20 mg tablets |
| Directions for Use | Take 1 tablet orally once daily.
Take with or without food.
Swallow whole, do not chew or crush. |
| Quantity Dispensed | _______________________ tablets |
| Refills | __________ |
| Pharmacist’s Signature | _______________________ |
| Pharmacist License # | __________ |
| DEA # (if required) | __________ |
---
📌 Quick‑Reference Highlights (for your internal use)
- Indication – Jakafi is indicated for adults with primary or secondary myelofibrosis.
- Typical Starting Dose – 50 mg once daily; may be titrated up to 100 mg depending on response and tolerability.
(The 20 mg strength is usually for maintenance or as an alternate daily dose in certain protocols.)
- Common Side Effects – GI upset, fatigue, nausea, vomiting, diarrhea, increased liver enzymes.
- Contraindications – Severe hepatic impairment, pregnancy (Category X), and concurrent use with certain CYP3A4 inhibitors unless monitored.
- Patient Counseling Points
- Take the same time each day.
- Report any abdominal pain, persistent nausea, or signs of bleeding.
- Check liver function tests at baseline and periodically.
- Avoid grapefruit juice and other known CYP3A4 inhibitors unless the prescriber approves.
---
💡 Tips for a Clear Label
1. Use legible font – 12‑point or larger if required by local regulations.
2. Include patient’s full name – avoid nicknames or initials.
3. State directions in plain language – use “take once daily” instead of abbreviations unless the patient is familiar.
4. Provide contact info – both pharmacy and prescriber phone numbers for quick questions.
5. Check legal requirements – some jurisdictions require specific wording such as “use under the direction of a licensed prescriber” or “do not exceed prescribed dosage.”
---
If you need a label for a specific patient or region, just let me know the details (e.g., quantity, refills, or local regulatory style), and I can tailor it further.